Name: CONTRAFECT CORP (CFRX) Stock
Brand: CONTRAFECT CORP
Rating: 3 (3 reviews)

CFRX Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: RAMP RMCO AMLX DNUT ...

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

2 years ago - By: Seeking Alpha

ContraFect files for stock and warrants offering to raise $15M (NASDAQ:CFRX)

2 years ago - By: Benzinga - Mentions: CHRS ICU LIPO ALGS ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 years ago - By: InvestorPlace - Mentions: NXU SASI YGMZ

Why Is Nxu (NXU) Stock Down Today?

2 years ago - By: InvestorPlace - Mentions: YGMZ

Why Is ContraFect (CFRX) Stock Up 23% Today?

2 years ago - By: InvestorPlace - Mentions: LMDX AKU HARP TGH ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: InvestorPlace - Mentions: ZAPP NXU ICU BCEL ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: InvestorPlace - Mentions: RAD NXU SASI

RAD Stock Sinks as Rite Aid Files for Ch. 11 Bankruptcy

2 years ago - By: InvestorPlace - Mentions: SASI YGMZ

Why Is Sigma Additive Solutions (SASI) Stock Down 27% Today?

2 years ago - By: ContraFect Corporation

ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study

2 years ago - By: ContraFect Corporation

ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study

2 years ago - By: InvestorPlace - Mentions: YGMZ RDHL MREO PCSA ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: InvestorPlace - Mentions: SPCB MOB IMUX TSBX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

2 years ago - By: ContraFect Corporation

ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development

2 years ago - By: ContraFect Corporation

ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370

2 years ago - By: ContraFect Corporation

ContraFect to Present at the World Anti-Microbial Resistance Congress 2023

2 years ago - By: Seeking Alpha

ContraFect enters a warrant exercise transaction for $9.6M (NASDAQ:CFRX)

2 years ago - By: ContraFect Corporation

ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million

2 years ago - By: ContraFect Corporation

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens

3 years ago - By: InvestorPlace - Mentions: WETG AHI SIEN BENF ...

CONTRAFECT CORP (CFRX) Stock News

CFRX Latest News, Press Relases and Analysis

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

ContraFect files for stock and warrants offering to raise $15M (NASDAQ:CFRX)

12 Health Care Stocks Moving In Friday's After-Market Session

Why Is Nxu (NXU) Stock Down Today?

Why Is ContraFect (CFRX) Stock Up 23% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

RAD Stock Sinks as Rite Aid Files for Ch. 11 Bankruptcy

Why Is Sigma Additive Solutions (SASI) Stock Down 27% Today?

ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study

ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development

ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370

ContraFect to Present at the World Anti-Microbial Resistance Congress 2023

ContraFect enters a warrant exercise transaction for $9.6M (NASDAQ:CFRX)

ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday